Cellens Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $6.6M

  • Investors
  • 19

Cellens General Information

Description

Developer of a cell surface scanning platform designed to assist oncologists in performing noninvasive detection of bladder cancer. The company's platform uses atomic force microscopy imaging and machine learning modeling to perform tests that quantify physio-biomarkers on cell surfaces extracted from urine samples to provide a diagnostic score for bladder cancer, enabling oncologists, urologists, and healthcare providers to reduce invasive, costly, and inaccurate procedures of bladder cancer diagnostics to optimize patient survival experience.

Contact Information

Website
www.cellensinc.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 529 Main Street
  • Suite 1M6
  • Boston, MA 02129
  • United States
+1 (857)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 529 Main Street
  • Suite 1M6
  • Boston, MA 02129
  • United States
+1 (857)

Cellens Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Early Stage VC 15-Aug-2025 $6.6M Completed Generating Revenue
14. Accelerator/Incubator 27-Sep-2024 Completed Generating Revenue
13. Accelerator/Incubator 09-Oct-2023 Completed Generating Revenue
12. Seed Round 14-Oct-2022 Completed Generating Revenue
11. Grant 05-Oct-2022 Completed Generating Revenue
10. Accelerator/Incubator 01-May-2022 Completed Generating Revenue
9. Seed Round 11-Jan-2022 Completed Generating Revenue
8. Accelerator/Incubator 01-Apr-2021 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2021 $21K Completed Startup
6. Accelerator/Incubator 01-Oct-2020 $1K $21K Completed Startup
To view Cellens’s complete valuation and funding history, request access »

Cellens Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2
Seed-3
To view Cellens’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cellens Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellens Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Blackwood Healthcare Breakthroughs Venture Capital Minority
CANCER FUND Venture Capital Minority
Kolon Industries Corporation Minority
Labcorp Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial

Cellens FAQs

  • When was Cellens founded?

    Cellens was founded in 2019.

  • Where is Cellens headquartered?

    Cellens is headquartered in Boston, MA.

  • What is the size of Cellens?

    Cellens has 10 total employees.

  • What industry is Cellens in?

    Cellens’s primary industry is Decision/Risk Analysis.

  • Is Cellens a private or public company?

    Cellens is a Private company.

  • What is the current valuation of Cellens?

    The current valuation of Cellens is .

  • What is Cellens’s current revenue?

    The current revenue for Cellens is .

  • How much funding has Cellens raised over time?

    Cellens has raised $7.5M.

  • Who are Cellens’s investors?

    ACS BrightEdge, Blackwood Healthcare Breakthroughs, CANCER FUND, Kolon Industries, and Labcorp Venture Fund are 5 of 19 investors who have invested in Cellens.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process